96 related articles for article (PubMed ID: 26002276)
1. (131)I-Nimotuzumab - A potential radioimmunotherapeutic agent in treatment of tumors expressing EGFR.
Kameswaran M; Samuel G; Dev Sarma H; Shinde SN; Dash A; Venkatesh M
Appl Radiat Isot; 2015 Aug; 102():98-102. PubMed ID: 26002276
[TBL] [Abstract][Full Text] [Related]
2. Preparation of
Pandey U; Kameswaran M; Gamre N; Dash A
J Labelled Comp Radiopharm; 2019 Apr; 62(4):158-165. PubMed ID: 30663095
[TBL] [Abstract][Full Text] [Related]
3. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
[TBL] [Abstract][Full Text] [Related]
4. Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors.
Vera DR; Eigner S; Henke KE; Lebeda O; Melichar F; Beran M
Nucl Med Biol; 2012 Jan; 39(1):3-13. PubMed ID: 21958849
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors.
Vera DR; Eigner S; Beran M; Henke KE; Laznickova A; Laznicek M; Melichar F; Chinol M
Cancer Biother Radiopharm; 2011 Jun; 26(3):287-97. PubMed ID: 21711096
[TBL] [Abstract][Full Text] [Related]
6. Induction of different cellular arrest and molecular responses in low EGFR expressing A549 and high EGFR expressing A431 tumor cells treated with various doses of
Suman S; Priya R; Kameswaran M
Int J Radiat Biol; 2020 Sep; 96(9):1144-1156. PubMed ID: 32657634
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.
Barta P; Laznickova A; Laznicek M; Vera DR; Beran M
J Labelled Comp Radiopharm; 2013 May; 56(5):280-8. PubMed ID: 24285372
[TBL] [Abstract][Full Text] [Related]
8. A potencial theranostic agent for EGF-R expression tumors: (177)Lu-DOTA-nimotuzumab.
Calzada V; Zhang X; Fernandez M; Diaz-Miqueli A; Iznaga-Escobar N; Deutscher SL; Balter H; Quinn TP; Cabral P
Curr Radiopharm; 2012 Oct; 5(4):318-24. PubMed ID: 22280117
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of
Kameswaran M; Sarma HD; Dash A
Appl Radiat Isot; 2017 May; 123():109-113. PubMed ID: 28260607
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor retention of radioiodinated anti-epidermal growth factor receptor antibody using novel bifunctional iodination linker for radioimmunotherapy.
Kim EJ; Kim BS; Choi DB; Chi SG; Choi TH
Oncol Rep; 2016 Jun; 35(6):3159-68. PubMed ID: 27035553
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of nimotuzumab (hR3) conjugated with
Nguyen TT; Ho AS; Nguyen TK; Nguyen TN; Bui VC; Nguyen TB; Dang HH; Nguyen DK; Nguyen TN; Nguyen LT
Int J Radiat Biol; 2021; 97(5):704-713. PubMed ID: 33617414
[TBL] [Abstract][Full Text] [Related]
12. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
[TBL] [Abstract][Full Text] [Related]
13. Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.
Lee FT; Mountain AJ; Kelly MP; Hall C; Rigopoulos A; Johns TG; Smyth FE; Brechbiel MW; Nice EC; Burgess AW; Scott AM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7080s-7086s. PubMed ID: 16203806
[TBL] [Abstract][Full Text] [Related]
14. Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.
Calzada V; García MF; Alonso-Martínez LM; Camachoc X; Goicochea E; Fernández M; Castillo AX; Díaz-Miqueli A; Iznaga-Escobar N; Montaña RL; Alonso O; Gambini JP; Cabral P
Anticancer Agents Med Chem; 2016; 16(9):1184-9. PubMed ID: 26961312
[TBL] [Abstract][Full Text] [Related]
15. Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma.
Sogawa C; Tsuji AB; Yoshida C; Inubushi M; Furukawa T; Koizumi M; Akahori Y; Ukai Y; Kurosawa G; Kurosawa Y; Saga T
Nucl Med Commun; 2012 Jul; 33(7):719-25. PubMed ID: 22453549
[TBL] [Abstract][Full Text] [Related]
16. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
[TBL] [Abstract][Full Text] [Related]
17. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro and experimental in vivo studies of the anti-epidermal growth factor receptor antibody nimotuzumab and its aglycosylated form produced in transgenic tobacco plants.
Rodríguez M; Pérez L; Gavilondo JV; Garrido G; Bequet-Romero M; Hernández I; Huerta V; Cabrera G; Pérez M; Ramos O; Leyva R; León M; Ramos PL; Triguero A; Hernández A; Sánchez B; Ayala M; Soto J; González E; Mendoza O; Tiel K; Pujol M
Plant Biotechnol J; 2013 Jan; 11(1):53-65. PubMed ID: 23046448
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
Reist CJ; Archer GE; Kurpad SN; Wikstrand CJ; Vaidyanathan G; Willingham MC; Moscatello DK; Wong AJ; Bigner DD; Zalutsky MR
Cancer Res; 1995 Oct; 55(19):4375-82. PubMed ID: 7671250
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
